DrugInfoSys

Glymidine

Also known as: Glycodiazine

Drug #345

Glymidine is oral hypoglycemic agent. Glymidine is used to reduce the blood sugar level in the treatment of type 2 diabetes mellitus.

Primary Characteristics

Glymidine is also known as Glycodiazine.

It is of Synthetic origin and belongs to Pyrimidine.

It belongs to Potassium Channel (ATP sensitive) antagonist pharmacological group on the basis of mechanism of action and also classified in Antidiabetic Agent, Sulfonylurea pharmacological group.

Molecular Weight: 331.3 · pKa: 5.7 · Solubility in Water: 1 in 10 · Solubility in Alcohol: 1 in 110 · Non-proprietary name: Glymidine.

Molecular structure of Glymidine

Pharmacokinetics

Absorption: Glymidine has an oral bioavailability is 97% (±2%), pre-systemic (first-pass) metabolism accounts for 5% (±5%).

Distribution: Glymidine has a plasma protein binding is 80%.

Elimination: it is metabolised via extensive by Liver, plasma half-life is 2-10 hr, renal excretion is 95%.

Advertisement

Indications

Glymidine is primarily indicated in conditions like Maturity onset diabetes, Non-insulin dependent diabetes mellitus.

Contraindications

Glymidine is contraindicated in conditions like Renal failure, Iddm, Ketosis, Hepatic failure.

Dosage

Glymidine's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
1 – 500 mgPOAs Required. Befere breakfast And if required an additional dose may be taken before meal.
Paediatric Dosage (20kg)
0 – 0Not Recommended in this Age Group
Neonatal Dosage (3kg)
0 – 0Not recommended in this age group

Drug Interactions

Unknown3 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Glymidine in overdosage may give rise to further complications which include Hypoglycemia.

Glymidine produces potentially life-threatening effects which include Hypoglycemia , Hypoglycemia, Hypoglycemia. Careful monitoring is needed with proper medical management.

The signs and symptoms that are produced after acute overdosage of Glymidine are Hypoglycemia.

Glymidine is known to cause more or less tolerable side effects which are usually transient. These include Arthralgia, Backache , Changes in LFT , dizziness, Dryness of mouth, Epigastric discomfort, Fatigue, GI upset, Pancytopenia , Pruritus , Skin rashes, Weakness.

Warnings / Precautions

Available Brands

None recorded.

Storage Conditions

Glymidine should be stored Tab.

Drug Classification

  1. 1.18.7.2Oral hypoglycemics